These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 23955077)

  • 21. A novel cysteine cathepsin inhibitor yields macrophage cell death and mammary tumor regression.
    Salpeter SJ; Pozniak Y; Merquiol E; Ben-Nun Y; Geiger T; Blum G
    Oncogene; 2015 Dec; 34(50):6066-78. PubMed ID: 25798843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis.
    Dey JH; Bianchi F; Voshol J; Bonenfant D; Oakeley EJ; Hynes NE
    Cancer Res; 2010 May; 70(10):4151-62. PubMed ID: 20460524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway.
    Thoennissen NH; O'Kelly J; Lu D; Iwanski GB; La DT; Abbassi S; Leiter A; Karlan B; Mehta R; Koeffler HP
    Oncogene; 2010 Jan; 29(2):285-96. PubMed ID: 19855437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated expression of DecR1 impairs ErbB2/Neu-induced mammary tumor development.
    Ursini-Siegel J; Rajput AB; Lu H; Sanguin-Gendreau V; Zuo D; Papavasiliou V; Lavoie C; Turpin J; Cianflone K; Huntsman DG; Muller WJ
    Mol Cell Biol; 2007 Sep; 27(18):6361-71. PubMed ID: 17636013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coordinated regulation of pathways for enhanced cell motility and chemotaxis is conserved in rat and mouse mammary tumors.
    Wang W; Wyckoff JB; Goswami S; Wang Y; Sidani M; Segall JE; Condeelis JS
    Cancer Res; 2007 Apr; 67(8):3505-11. PubMed ID: 17440055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
    Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
    Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.
    Lee YK; So IS; Lee SC; Lee JH; Lee CW; Kim WM; Park MK; Lee ST; Park DY; Shin DY; Park CU; Kim YS
    J Gene Med; 2005 Feb; 7(2):145-57. PubMed ID: 15546163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Runx1 is associated with breast cancer progression in MMTV-PyMT transgenic mice and its depletion in vitro inhibits migration and invasion.
    Browne G; Taipaleenmäki H; Bishop NM; Madasu SC; Shaw LM; van Wijnen AJ; Stein JL; Stein GS; Lian JB
    J Cell Physiol; 2015 Oct; 230(10):2522-32. PubMed ID: 25802202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cystatin C deficiency suppresses tumor growth in a breast cancer model through decreased proliferation of tumor cells.
    Završnik J; Butinar M; Prebanda MT; Krajnc A; Vidmar R; Fonović M; Grubb A; Turk V; Turk B; Vasiljeva O
    Oncotarget; 2017 Sep; 8(43):73793-73809. PubMed ID: 29088746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer.
    Guo Y; Mazar AP; Lebrun JJ; Rabbani SA
    Cancer Res; 2002 Aug; 62(16):4678-84. PubMed ID: 12183425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct roles for cysteine cathepsin genes in multistage tumorigenesis.
    Gocheva V; Zeng W; Ke D; Klimstra D; Reinheckel T; Peters C; Hanahan D; Joyce JA
    Genes Dev; 2006 Mar; 20(5):543-56. PubMed ID: 16481467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of fetuin-A (alpha2-HS-glycoprotein) reduces mammary tumor incidence and prolongs tumor latency via the transforming growth factor-beta signaling pathway in a mouse model of breast cancer.
    Guillory B; Sakwe AM; Saria M; Thompson P; Adhiambo C; Koumangoye R; Ballard B; Binhazim A; Cone C; Jahanen-Dechent W; Ochieng J
    Am J Pathol; 2010 Nov; 177(5):2635-44. PubMed ID: 20847285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of novel cathepsin-X inhibitors in vitro and in vivo and their ability to improve cathepsin-B-directed antitumor therapy.
    Mitrović A; Završnik J; Mikhaylov G; Knez D; Pečar Fonović U; Matjan Štefin P; Butinar M; Gobec S; Turk B; Kos J
    Cell Mol Life Sci; 2022 Jan; 79(1):34. PubMed ID: 34989869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein tyrosine phosphatase receptor type O expression in the tumor niche correlates with reduced tumor growth, angiogenesis, circulating tumor cells and metastasis of breast cancer.
    Liu Z; Hou J; Ren L; He J; Sun B; Sun LZ; Wang S
    Oncol Rep; 2015 Apr; 33(4):1908-14. PubMed ID: 25646811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progression.
    Bengsch F; Buck A; Günther SC; Seiz JR; Tacke M; Pfeifer D; von Elverfeldt D; Sevenich L; Hillebrand LE; Kern U; Sameni M; Peters C; Sloane BF; Reinheckel T
    Oncogene; 2014 Sep; 33(36):4474-84. PubMed ID: 24077280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ADAMTS1 protease gene is required for mammary tumor growth and metastasis.
    Ricciardelli C; Frewin KM; Tan Ide A; Williams ED; Opeskin K; Pritchard MA; Ingman WV; Russell DL
    Am J Pathol; 2011 Dec; 179(6):3075-85. PubMed ID: 22001177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VEGF-A induces angiogenesis by perturbing the cathepsin-cysteine protease inhibitor balance in venules, causing basement membrane degradation and mother vessel formation.
    Chang SH; Kanasaki K; Gocheva V; Blum G; Harper J; Moses MA; Shih SC; Nagy JA; Joyce J; Bogyo M; Kalluri R; Dvorak HF
    Cancer Res; 2009 May; 69(10):4537-44. PubMed ID: 19435903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three-dimensional cultures modeling premalignant progression of human breast epithelial cells: role of cysteine cathepsins.
    Mullins SR; Sameni M; Blum G; Bogyo M; Sloane BF; Moin K
    Biol Chem; 2012 Dec; 393(12):1405-16. PubMed ID: 23667900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of cathepsin B on the interstitial fluid proteome of murine breast cancers.
    Gomez-Auli A; Hillebrand LE; Biniossek ML; Peters C; Reinheckel T; Schilling O
    Biochimie; 2016 Mar; 122():88-98. PubMed ID: 26455267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trial of the cysteine cathepsin inhibitor JPM-OEt on early and advanced mammary cancer stages in the MMTV-PyMT-transgenic mouse model.
    Schurigt U; Sevenich L; Vannier C; Gajda M; Schwinde A; Werner F; Stahl A; von Elverfeldt D; Becker AK; Bogyo M; Peters C; Reinheckel T
    Biol Chem; 2008 Aug; 389(8):1067-74. PubMed ID: 18710344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.